Cibc World Market Inc. increased its position in shares of Centene Corporation (NYSE:CNC - Free Report) by 410.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 395,879 shares of the company's stock after purchasing an additional 318,360 shares during the period. Cibc World Market Inc. owned 0.08% of Centene worth $24,592,000 at the end of the most recent quarter.
Several other large investors have also recently bought and sold shares of CNC. Frank Rimerman Advisors LLC grew its position in shares of Centene by 3.7% in the 3rd quarter. Frank Rimerman Advisors LLC now owns 4,521 shares of the company's stock valued at $281,000 after buying an additional 163 shares during the last quarter. Journey Retirement Planning & Investment Management LLC lifted its position in Centene by 3.9% in the third quarter. Journey Retirement Planning & Investment Management LLC now owns 4,652 shares of the company's stock valued at $289,000 after acquiring an additional 175 shares during the last quarter. Grove Bank & Trust lifted its position in Centene by 2.0% in the third quarter. Grove Bank & Trust now owns 11,294 shares of the company's stock valued at $702,000 after acquiring an additional 220 shares during the last quarter. GoalVest Advisory LLC lifted its position in Centene by 25.9% in the third quarter. GoalVest Advisory LLC now owns 1,122 shares of the company's stock valued at $70,000 after acquiring an additional 231 shares during the last quarter. Finally, Activest Wealth Management boosted its stake in Centene by 27.4% in the third quarter. Activest Wealth Management now owns 1,163 shares of the company's stock valued at $72,000 after acquiring an additional 250 shares in the last quarter. Hedge funds and other institutional investors own 93.63% of the company's stock.
Insider Activity
In related news, General Counsel Christopher Koster sold 56,500 shares of the firm's stock in a transaction dated Wednesday, August 26th. The stock was sold at an average price of $66.90, for a total transaction of $3,779,850.00. Following the transaction, the general counsel owned 248,854 shares of the company's stock, valued at $16,648,332.60. This trade represents a 18.50% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.37% of the stock is currently owned by corporate insiders.
Centene Stock Down 6.8%
Shares of NYSE:CNC opened at $67.64 on Thursday. The stock has a market cap of $33.49 billion, a P/E ratio of 23.17, a P/E/G ratio of 0.42 and a beta of 1.07. The firm has a fifty day moving average price of $67.45 and a 200 day moving average price of $56.94. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.16 and a quick ratio of 1.16. Centene Corporation has a 1-year low of $31.63 and a 1-year high of $78.08.
Centene (NYSE:CNC - Get Free Report) last issued its quarterly earnings data on Tuesday, October 27th. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.48. The company had revenue of $50.65 billion for the quarter, compared to the consensus estimate of $47.12 billion. Centene had a net margin of 0.72% and a return on equity of 12.15%. Centene's revenue for the quarter was up 1.9% on a year-over-year basis. During the same period last year, the firm posted $0.50 EPS. Sell-side analysts predict that Centene Corporation will post 5.27 EPS for the current year.
Analyst Upgrades and Downgrades
CNC has been the topic of several research reports. Morgan Stanley set a $71.00 price objective on Centene and gave the stock an "equal weight" rating in a report on Wednesday, October 28th. Weiss Ratings raised Centene from a "sell (d+)" rating to a "hold (c-)" rating in a report on Wednesday, October 28th. Robert W. Baird upped their target price on Centene from $66.00 to $71.00 and gave the company a "neutral" rating in a research report on Wednesday, October 28th. Cantor Fitzgerald upped their target price on Centene from $75.00 to $79.00 and gave the company an "overweight" rating in a research report on Wednesday, October 28th. Finally, UBS Group raised their price target on Centene from $70.00 to $78.00 and gave the stock a "neutral" rating in a research note on Wednesday, October 28th. Nine investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $75.10.
Read Our Latest Analysis on Centene
Centene Profile
(
Free Report)
Centene Corporation is a U.S. health care company that provides managed care and related services, primarily for people enrolled in government-sponsored health programs. Its offerings include Medicaid and Medicare plans, as well as health insurance sold through the Affordable Care Act marketplace. Centene serves members through health plans and a network of health care providers. Its businesses include Ambetter, which offers marketplace health plans, and Wellcare, which provides Medicare-related coverage.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Centene, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.
While Centene currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.